Stock Ideas
Stocks
Funds
Screener
Sectors
Watchlists
AMEH

AMEH - Apollo Medical Holdings Inc Stock Price, Fair Value and News

49.02USD-1.79 (-3.52%)Delayed as of 18 Jul 2024, 02:02 pm ET

Market Summary

AMEH
USD49.02-1.79
Delayedas of 18 Jul 2024, 02:02 pm
-3.52%

AMEH Stock Price

View Fullscreen

AMEH RSI Chart

AMEH Valuation

Market Cap

2.8B

Price/Earnings (Trailing)

45.6

Price/Sales (Trailing)

1.96

EV/EBITDA

21.59

Price/Free Cashflow

65.27

AMEH Price/Sales (Trailing)

AMEH Profitability

EBT Margin

6.50%

Return on Equity

9.55%

Return on Assets

5.09%

Free Cashflow Yield

1.53%

AMEH Fundamentals

AMEH Revenue

Revenue (TTM)

1.5B

Rev. Growth (Yr)

19.9%

Rev. Growth (Qtr)

14.54%

AMEH Earnings

Earnings (TTM)

62.4M

Earnings Growth (Yr)

12.97%

Earnings Growth (Qtr)

20.06%

Breaking Down AMEH Revenue

52 Week Range

52.10
(Low)(High)

Last 7 days

13.1%

Last 30 days

21.9%

Last 90 days

37.2%

Trailing 12 Months

45.9%

How does AMEH drawdown profile look like?

AMEH Financial Health

Current Ratio

1.52

Debt/Equity

0.56

Debt/Cashflow

0.18

AMEH Investor Care

Buy Backs (1Y)

2.64%

Diluted EPS (TTM)

1.32

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
20241.5B000
20231.2B1.3B1.3B1.4B
2022861.1M955.2M1.0B1.1B
2021698.1M708.6M755.6M773.9M
2020630.0M695.2M705.7M717.4M
2019491.7M499.1M488.5M560.6M
2018394.9M476.0M545.6M519.9M
2017128.0M157.2M239.7M356.4M
201644.0M46.2M49.5M54.5M
201533.0M39.1M38.8M41.8M
201410.8M12.1M20.9M25.7M
20136.6M7.1M9.3M10.3M
20125.1M5.7M6.3M6.8M
20113.9M4.2M4.5M4.8M
20100000
GRUFITY'S FAIR VALUE MODEL

Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed Russell 2000 Index

Small Caps and Mid Caps are mostly overlooked by investors as all the focus goes to Magnificent 7. These stocks that are not part of the beauty contest require a deeper look. However, all large cap stocks were once small caps. Grufity's Fair Value model opens up this unverse as it separates high-performing, rewarding stocks from low-performing risky stocks. <b>Russell 2000 stocks that were marked 'Very Cheap' by the model doubled in three years while the index was flat.</b>

PurpleZone


Returns of $10,000 invested in:

Very Cheap Stocks: $21,859
Russell 2000 Index: $10,334
Very Expensive Stocks: $8,224


Russell 2000 stocks considered 'Very Cheap' by the model greatly outperformed Russell 2000 index and the 'Very Expensive' bucket over past three years.

Russell 2000 Index
Very Expensive Stocks
Very Cheap Stocks
Try For Just $1.99

Tracking the Latest Insider Buys and Sells of Apollo Medical Holdings Inc

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
Jan 23, 2024
kumar dinesh m.
acquired
-
-
150,395
see remarks
Dec 15, 2023
marsh linda
acquired
-
-
3,650
-
Dec 15, 2023
mazdyasni matthew
acquired
-
-
4,750
-
Dec 15, 2023
vong john
acquired
-
-
14,352
chief accounting officer
Dec 15, 2023
dai, weili
acquired
-
-
3,650
-
Dec 15, 2023
chiang john
acquired
-
-
4,750
-
Dec 15, 2023
schmidt david
acquired
-
-
5,750
-
Dec 15, 2023
lam thomas s.
acquired
-
-
90,000
president and co-ceo
Dec 15, 2023
sim kenneth t.
acquired
-
-
90,000
executive chairman
Dec 15, 2023
kitayama mitchell w
acquired
-
-
6,750
-

1–10 of 50

Which funds bought or sold AMEH recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
Jul 16, 2024
NorthCrest Asset Manangement, LLC
reduced
-2.46
-493,895
8,053,720
0.27%
Jul 16, 2024
SJS Investment Consulting Inc.
added
125
198
366
-%
Jul 15, 2024
JFS WEALTH ADVISORS, LLC
added
142
396
690
-%
Jul 15, 2024
Granite Bay Wealth Management, LLC
added
6,200
24,565,000
24,985,000
0.25%
Jul 12, 2024
QRG CAPITAL MANAGEMENT, INC.
added
8.27
9,702
221,458
-%
Jul 12, 2024
SG Americas Securities, LLC
sold off
-100
-113,000
-
-%
Jul 12, 2024
Opal Wealth Advisors, LLC
new
-
17,563
17,563
0.01%
Jul 10, 2024
CWM, LLC
added
10.66
-
5,000
-%
Jul 10, 2024
Linden Thomas Advisory Services, LLC
added
9.98
24,971
425,556
0.07%
Jul 08, 2024
Versant Capital Management, Inc
sold off
-100
-5,501
-
-%

1–10 of 46

Are Funds Buying or Selling AMEH?

Are funds buying AMEH calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own AMEH
No. of Funds

Unveiling Apollo Medical Holdings Inc's Major ShareHolders

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 13, 2024
vanguard group inc
8.66%
5,049,928
SC 13G/A
Jan 23, 2024
blackrock inc.
13.5%
6,498,075
SC 13G/A
Nov 17, 2023
allied physicians of california, a profession medical corp
12.9%
7,132,698
SC 13D/A
Feb 09, 2023
vanguard group inc
7.83%
4,438,955
SC 13G/A
Jan 26, 2023
blackrock inc.
11.5%
6,514,440
SC 13G/A
Jan 20, 2023
blackrock inc.
11.5%
6,514,440
SC 13G/A
Feb 09, 2022
vanguard group inc
7.02%
3,897,315
SC 13G
Jan 28, 2022
blackrock inc.
10.7%
5,960,508
SC 13G/A
Oct 08, 2021
blackrock inc.
10.6%
5,867,352
SC 13G
Jul 08, 2021
allied physicians of california, a profession medical corp
20.0%
10,993,301
SC 13D/A

Recent SEC filings of Apollo Medical Holdings Inc

View All Filings
Date Filed Form Type Document
Jul 15, 2024
424B7
Prospectus Filed
Jul 15, 2024
8-K
Current Report
Jul 12, 2024
4
Insider Trading
Jun 13, 2024
8-K
Current Report
Jun 12, 2024
8-K
Current Report
Jun 12, 2024
S-8
Employee Benefits Plan
May 21, 2024
8-K
Current Report
May 17, 2024
4
Insider Trading
May 15, 2024
8-K
Current Report
May 14, 2024
4
Insider Trading

Peers (Alternatives to Apollo Medical Holdings Inc)

NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
527.6B
379.5B
17.16% 14.64%
34.34
1.39
12.96% -25.81%
97.9B
206.0B
3.25% 21.04%
25.41
0.48
12.55% -43.95%
84.6B
66.7B
-3.71% 11.48%
15.47
1.27
9.59% -4.59%
77.4B
360.9B
0.87% -14.78%
10.56
0.21
9.07% 78.83%
36.2B
155.5B
-0.60% 2.20%
13.23
0.23
6.34% 84.42%
12.4B
14.7B
-3.17% 20.11%
15.13
0.84
7.99% 19.23%
12.3B
12.3B
-1.08% 31.60%
15.02
0.99
5.77% 58.74%
MID-CAP
8.3B
2.3B
1.96% 0.37%
29.3
3.62
5.96% 18.29%
6.2B
3.0B
2.19% -9.54%
-552.02
2.08
10.92% -104.06%
2.8B
1.5B
21.89% 45.94%
45.6
1.96
19.34% 40.15%
2.2B
3.5B
5.86% -48.07%
15.05
0.62
-27.67% -62.40%
SMALL-CAP
2.0B
1.1B
3.76% 32.65%
30.42
1.84
11.45% 30.74%
1.5B
3.0B
16.94% 110.63%
-8.57
0.49
4.98% 4.88%
74.5M
-
19.41% -11.29%
-4.93
-
- -1.05%
20.6M
21.6M
-1.23% 21.21%
40.5
0.95
9.04% -57.88%

Apollo Medical Holdings Inc News

Latest updates
Yahoo Finance4 months ago

Apollo Medical Holdings Inc Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)
(In Millions)
Income Statement (Quarterly)
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2024Q12023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q22020Q12019Q42019Q32019Q2
Revenue14.5%404353348348337294317270263195227176176177180165195165179156130
Costs and Expenses4.9%374357309321315282267254237193174155154137143152189161168146115
Operating Expenses-------------------168146115
  S&GA Expenses2.0%39.0038.0029.0024.0021.0024.0021.0020.0012.0017.0022.0014.009.009.0016.0012.00-12.0011.008.0012.00
EBITDA Margin2.9%0.09*0.09*0.10*0.10*0.09*0.10*0.07*0.03*0.11*0.13*0.20*0.27*---------
Interest Expenses39.9%8.005.004.004.003.003.002.002.001.001.001.002.002.001.002.003.00-3.003.001.000.00
Income Taxes601.9%7.001.0010.0014.007.0011.0017.005.007.00-4.28-0.2828.008.0013.0011.0032.00-2.002.004.004.00
Earnings Before Taxes2499.2%24.001.0038.0031.0019.0010.0041.0017.0018.00-22.43-5.5084.0021.0024.0036.001136.005.000.0014.0015.00
EBT Margin0.3%0.06*0.06*0.07*0.08*0.07*0.08*0.05*0.01*0.09*0.10*0.16*0.23*---------
Net Income20.1%15.0012.0022.0013.0013.00-3.7323.0012.0014.0012.0034.0010.0012.0010.0017.007.006.004.007.004.004.00
Net Income Margin-1.9%0.04*0.04*0.03*0.04*0.04*0.04*0.06*0.08*0.08*0.09*0.09*0.07*---------
Free Cashflow-54.2%6.0012.0011.0014.002.0084.00-39.088.007.00-14.9942.0014.00---------
Balance Sheet
(In Millions)
Balance Sheet
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2024Q12023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q1
Assets31.4%1,2269331,0731,027999966955967923867871896843817814833724729750568521
  Current Assets16.8%539462476465455428446468445404427472370339367381318329321168177
    Cash Equivalents14.0%33529427429427528818423423823320517720619416615281.0010423053.0093.00
  Net PPE-------------------12.0012.0012.00
  Goodwill47.1%410279276274269269251247246246237232232232239239239239237209186
Liabilities48.1%774523458444434408410447397357346356382372386414369368382163126
  Current Liabilities62.5%35521920318617314915618515611511512612311513115310710510578.0088.00
  Long Term Debt42.3%368259206205205203199199183183183183227230226230230232234--
    LT Debt, Current6.4%21.0020.003.003.001.001.003.002.002.001.000.000.0012.0011.0010.0010.0010.0010.0010.00--
    LT Debt, Non Current42.3%368259206205205203199199183183183183227230226230230232234--
Shareholder's Equity6.4%653614594570551544504480473454435399347329229208198192192186182
  Retained Earnings6.1%25824323120919618218616315113712590.0080.0068.0060.0043.0036.0032.0025.0021.0018.00
  Additional Paid-In Capital6.6%395371363357353360315311316311306306266261169164161160166164163
Shares Outstanding1.3%47.0047.0047.0047.0046.0047.0045.0045.0045.0045.0044.0044.00---------
Minority Interest84.3%4.002.004.004.003.002.003.006.006.006.004.003.001.000.001.001.001.001.001.001.001.00
Float----1,300---1,500---2,400---504---480-
Cashflow (Last 12 Months)
(In Thousands)
Cashflow (Quarterly)
(In Thousands)
(*) denotes actual numbers (not divided by Thousands)
Description(%) Q/Q2024Q12023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q1
Cashflow From Operations-69.0%5,97719,30015,40525,8027,72084,939-35,8709,02124,038-12,19051,23921,3349,952-2,60136,18921,868-9,2933,58832,102-18,050-3,967
  Share Based Compensation-33.7%5,7488,6765,7064,2133,4455,6243,5023,9203,0552,4231,4201,5561,3468256009001,058541330331345
Cashflow From Investing-521.7%-71,039-11,427-34,875-5,186-14,03513,201-8,0867,497-19,72539,084-12,742-10,49469229,096-75368,093-943-120,267-10,117-50,135-112
Cashflow From Financing786.8%106,35111,993-510-963-7,0995,871-6,251-20,2375321,435-11,016-39,4291,262647-21,795-18,487-12,061-10,376152,07631,441-9,810
  Dividend Payments-99.8%95.0059,8081,4247221201,35412011,3781,178-9,97921,1064.001,18619,946-9,9341,04749,72894210,000
  Buy Backs---1509,539--4231689,300230-2,7582,639342-1,0227713624267,530--40.00
Get Full Access to Grufity – and Unlimited Downloads
Gain full access to fair value, watchlists, stock screener, unlimited page visits, and additional features by joining as a member today for just $1.99.
Try For Just $1.99

AMEH Income Statement

2024-03-31
CONDENSED CONSOLIDATED STATEMENTS OF INCOME - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Revenue  
Total revenue$ 404,356$ 337,244
Operating expenses  
Cost of services, excluding depreciation and amortization330,399289,397
General and administrative expenses38,72221,182
Depreciation and amortization5,0964,292
Total expenses374,217314,871
Income from operations30,13922,373
Other income (expense)  
Income from equity method investments6322,484
Interest expense(7,585)(3,269)
Interest income3,9963,009
Unrealized gain (loss) on investments1,099(6,392)
Other (loss) income(4,277)1,204
Total other expenses, net(6,135)(2,964)
Income before provision for income taxes24,00419,409
Provision for income taxes7,1426,921
Net income16,86212,488
Net income (loss) attributable to non-controlling interest2,027(644)
Net income attributable to Astrana Health, Inc.$ 14,835$ 13,132
Earnings per share – basic (in dollars per share)$ 0.31$ 0.28
Earnings per share – diluted (in dollars per share)$ 0.31$ 0.28
Capitation, net  
Revenue  
Total revenue$ 365,910$ 300,204
Risk pool settlements and incentives  
Revenue  
Total revenue17,37713,462
Management fee income  
Revenue  
Total revenue4,0789,896
Fee-for-service, net  
Revenue  
Total revenue15,93712,062
Other revenue  
Revenue  
Total revenue$ 1,054$ 1,620

AMEH Balance Sheet

2024-03-31
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Current assets  
Cash and cash equivalents$ 334,796$ 293,807
Investment in marketable securities2,4902,498
Income taxes receivable010,657
Other receivables1,7831,335
Prepaid expenses and other current assets17,28117,450
Total current assets538,810461,507
Non-current assets  
Land, property and equipment, net7,9857,171
Intangible assets, net119,70771,648
Goodwill410,267278,831
Income taxes receivable15,94315,943
Investments in other entities – equity method35,89325,774
Investments in privately held entities6,3966,396
Restricted cash645345
Operating lease right-of-use assets39,15237,396
Other assets4,0671,877
Total non-current assets687,467471,854
Total assets[1]1,226,277933,361
Current liabilities  
Accounts payable and accrued expenses146,47359,949
Fiduciary accounts payable7,7927,737
Medical liabilities136,494106,657
Income taxes payable5,5220
Dividend payable638638
Finance lease liabilities636646
Operating lease liabilities5,0074,607
Current portion of long-term debt20,75019,500
Other liabilities31,96018,940
Total current liabilities355,272218,674
Non-current liabilities  
Deferred tax liability3,7564,072
Finance lease liabilities, net of current portion1,0151,033
Operating lease liabilities, net of current portion37,71636,289
Long-term debt, net of current portion and deferred financing costs368,448258,939
Other long-term liabilities7,6523,586
Total non-current liabilities418,587303,919
Total liabilities[1]773,859522,593
Commitments and contingencies (Note 12)
Mezzanine equity  
Noncontrolling interest in Allied Physicians of California, a Professional Medical Corporation ("APC")(205,557)(205,883)
Stockholders’ equity  
Common stock, value, issued4847
Additional paid-in capital395,473371,037
Retained earnings257,969243,134
Total stockholders’ equity653,490614,218
Non-controlling interest4,4852,433
Total equity657,975616,651
Total liabilities, mezzanine equity and equity1,226,277933,361
Series A Preferred Stock  
Stockholders’ equity  
Preferred stock00
Series B Preferred Stock  
Stockholders’ equity  
Preferred stock00
Nonrelated Party  
Current assets  
Receivables, net120,10676,780
Non-current assets  
Loans receivable, non-current47,41226,473
Related Party  
Current assets  
Receivables, net$ 62,354$ 58,980
[1]The Company’s condensed consolidated balance sheets include the assets and liabilities of its consolidated VIEs. The condensed consolidated balance sheets include total assets that can be used only to settle obligations of the Company’s consolidated VIEs totaling $717.5 million and $540.8 million as of March 31, 2024 and December 31, 2023, respectively, and total liabilities of the Company’s consolidated VIEs for which creditors do not have recourse to the general credit of the primary beneficiary of $179.6 million and $146.0 million as of March 31, 2024 and December 31, 2023, respectively. These VIE balances do not include $299.5 million of investment in affiliates and $110.1 million of amounts due to affiliates as of March 31, 2024, and $273.2 million of investment in affiliates and $107.3 million of amounts due to affiliates as of December 31, 2023, as these are eliminated upon consolidation and not presented within the condensed consolidated balance sheets. See Note 16 — “Variable Interest Entities (VIEs)” for further details.
AMEH
Apollo Medical Holdings, Inc., a physician-centric technology-powered healthcare company, provides medical care services in the United States. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. The company's physician network consists of primary care physicians, specialist physicians, and hospitalists. It serves patients, primarily covered by private or public insurance, such as Medicare, Medicaid, and health maintenance organization plans; and non-insured patients in California. The company was incorporated in 1985 and is headquartered in Alhambra, California.
 CEO
 WEBSITEapollomed.net
 INDUSTRYHealthcare Plans
 EMPLOYEES1362

Apollo Medical Holdings Inc Frequently Asked Questions


What is the ticker symbol for Apollo Medical Holdings Inc? What does AMEH stand for in stocks?

AMEH is the stock ticker symbol of Apollo Medical Holdings Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Apollo Medical Holdings Inc (AMEH)?

As of Wed Jul 17 2024, market cap of Apollo Medical Holdings Inc is 2.85 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of AMEH stock?

You can check AMEH's fair value in chart for subscribers.

What is the fair value of AMEH stock?

You can check AMEH's fair value in chart for subscribers. The fair value of Apollo Medical Holdings Inc is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Apollo Medical Holdings Inc is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for AMEH so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Apollo Medical Holdings Inc a good stock to buy?

The fair value guage provides a quick view whether AMEH is over valued or under valued. Whether Apollo Medical Holdings Inc is cheap or expensive depends on the assumptions which impact Apollo Medical Holdings Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for AMEH.

What is Apollo Medical Holdings Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Wed Jul 17 2024, AMEH's PE ratio (Price to Earnings) is 45.6 and Price to Sales (PS) ratio is 1.96. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. AMEH PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Apollo Medical Holdings Inc's stock?

In the past 10 years, Apollo Medical Holdings Inc has provided 0.228 (multiply by 100 for percentage) rate of return.